可选产品分析
经您允许,我们会使用注重隐私的有限分析来了解哪些研究流程有效。我们不会使用广告跟踪器或会话录制。您可以在偏好设置中更改此选择。请阅读 隐私政策.
Fortive Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $17.5B | |
|---|---|---|
| Revenue (ttm) | 4.3B | |
| Net income (ttm) | 534.4M | |
| EPS (ttm) | $1.68 | |
| Shares out | 302M | |
| P/E (trailing) | 37.9x | |
| P/E (forward) | 17.3x | |
| Dividend | $0.28 (0.44%) | |
| Volume | 5,333,165 | |
| Beta | 0.99 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $5.25B | $5.83B | $3.91B | $4.08B | $4.16B | -5.7% |
| Gross profit | $3.01B | $3.36B | $2.48B | $2.62B | $2.64B | -3.2% |
| Operating income | $812.8M | $987.4M | $574.0M | $716.3M | $720.2M | -3.0% |
| Net income | $608.4M | $755.2M | $865.8M | $832.9M | $579.2M | -1.2% |
| EPS (diluted) | $1.23 | $1.58 | $2.43 | $2.36 | $1.73 | +8.9% |
| EBITDA | $1.18B | $1.44B | $1.13B | $1.67B | $1.20B | +0.5% |
| R&D | $354.8M | $401.5M | $237.0M | $251.3M | $259.2M | -7.5% |
| SG&A | $1.84B | $1.96B | $1.67B | $1.65B | $1.66B | -2.5% |
Recent company headlines from major financial publishers.
The base case projects intrinsic value reaching $52.99 with an assigned probability of 60.0%, offering an implied return of -7.5% relative to $57.26 (as of 2026-10-09). This trajectory assumes steady mid-single-digit organic growth across Intelligent Operating Solutions, continuous Fortive Business System operational improvements expanding operating margins through FY2030, and disciplined share repurchases. Disconfirmation would occur if segment operating margins deteriorate or if industrial capex freezes in North America and EMEA.
The bull case models upside reaching $60.16 with a probability of 20.0%, generating an implied return of 5.1% from $57.26 (as of 2026-10-09). This outcome requires accelerated conversion of legacy hardware clients into recurring cloud software subscriptions within Intelligent Operating Solutions, accompanied by stronger hospital procedure volumes in healthcare sterilization. Faster margin expansion toward Potential value of $60.16 would be disconfirmed if peer competition limits software pricing power.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.4% | $56.7 | $57.6 | $58.6 | $59.6 | $60.8 |
| 8.9% | $54.0 | $54.8 | $55.6 | $56.4 | $57.4 |
| 9.4% | $51.7 | $52.3 | $53.0 | $53.7 | $54.5 |
| 9.9% | $49.6 | $50.1 | $50.7 | $51.3 | $52.0 |
| 10.4% | $47.7 | $48.2 | $48.7 | $49.2 | $49.8 |
Upcoming earnings date and setup when available.
每月发布的研究版本所给出的评级。评级比较分析日的价格与公允价值,并不记录判断是否正确。
| 年份 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |